000 | 01488 a2200421 4500 | ||
---|---|---|---|
005 | 20250517063308.0 | ||
264 | 0 | _c20160425 | |
008 | 201604s 0 0 eng d | ||
022 | _a1759-4782 | ||
024 | 7 |
_a10.1038/nrclinonc.2015.203 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNarod, Steven | |
245 | 0 | 0 |
_aBreast cancer: The importance of overdiagnosis in breast-cancer screening. _h[electronic resource] |
260 |
_bNature reviews. Clinical oncology _cJan 2016 |
||
300 |
_a5-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aCarcinoma, Intraductal, Noninfiltrating _xdiagnosis |
650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 | _aDiagnostic Errors |
650 | 0 | 4 | _aEarly Detection of Cancer |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMammography |
650 | 0 | 4 |
_aMass Screening _xadverse effects |
650 | 0 | 4 | _aMastectomy, Segmental |
650 | 0 | 4 | _aMedical Overuse |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUnited States |
773 | 0 |
_tNature reviews. Clinical oncology _gvol. 13 _gno. 1 _gp. 5-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrclinonc.2015.203 _zAvailable from publisher's website |
999 |
_c25452976 _d25452976 |